tiprankstipranks
pc:kisoj

KisoJi Biotechnology Inc

KisoJi Biotechnology Inc. is a biotechnology company dedicated to the discovery and development of transformative antibody therapeutics. The company is advancing its lead asset, KJ-103, a potent naked antibody targeting TROP2, into clinical trials for the treatment of solid tumors. Additionally, KisoJi is leveraging its innovative antibody discovery platform to develop new multi-specific therapeutic antibody drugs targeting cardiometabolic diseases, as well as immunology and inflammation.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$41M
Total Amount Raised$41M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$41M
Latest Funding Amount$41M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 14, 2025
Investment
$41.00M

Investors

Investor Name
Funding Round

Related News and Analysis